The dilemma of DCIS

Breast

Volumn 16, Issue 2 SUPPL., 2007, Pages 59-62

  Morrow, Monica ^a   O'Sullivan, Martin J ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

DCIS; Patient preference; Radiotherapy

Indexed keywords

AROMATASE INHIBITOR; PLACEBO; TAMOXIFEN;

ADJUVANT THERAPY; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL TRIAL; DISEASE MARKER; HUMAN; MAMMOGRAPHY; MASTECTOMY; PRIORITY JOURNAL; RECURRENT CANCER; RISK REDUCTION; SURVIVAL TIME; TREATMENT FAILURE;

EID: 35648953199     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.07.015     Document Type: Article

References (24)

1. Rosner D., Bedwani R.N., Vana J., et al. Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons. Ann Surg 192 2 (1980) 139-147
2. Ernster V.L., Barclay J., Kerlikowske K., et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275 12 (1996) 913-918
3. Newman L. Lobular carcinoma in situ: clinical management. In: Harris J.R., Lippman M.E., Morrow M., and Osborne C.K. (Eds). Diseases of the breast. 3rd ed (2004), Lippincott Williams & Wilkins, Philadelphia, PA 497-506
4. Fisher B., Land S., Mamounas E., et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 28 4 (2001) 400-418
5. Bijker N., Meijnen P., Peterse J.L., et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24 21 (2006) 3381-3387
6. Jha M.K., Avlonitis V.S., Griffith C.D., et al. Aggressive local treatment for screen-detected DCIS results in very low rates of recurrence. Eur J Surg Oncol 27 5 (2001) 454-458
7. Boyages J., Delaney G., and Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 85 3 (1999) 616-628
8. Mirza N.Q., Vlastos G., Meric F., et al. Ductal carcinoma-in-situ: long-term results of breast-conserving therapy. Ann Surg Oncol 7 9 (2000) 656-664
9. Rodrigues N., Carter D., Dillon D., et al. Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy. Int J Radiat Oncol Biol Phys 54 5 (2002) 1331-1335
10. Vargas C., Kestin L., Go N., et al. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys 63 5 (2005) 1514-1521
11. Silverstein M.J., Lagios M.D., Groshen S., et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340 19 (1999) 1455-1461
12. Schwartz G.F., Finkel G.C., Garcia J.C., and Patchefsky A.S. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer 70 10 (1992) 2468-2474
13. Lagios M.D., Margolin F.R., Westdahl P.R., and Rose M.R. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63 4 (1989) 618-624
14. Houghton J., George W.D., Cuzick J., et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 362 9378 (2003) 95-102
15. Emdin S.O., Granstrand B., Ringberg A., et al. SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol 45 5 (2006) 536-543
16. Hughes L., Wang M., Page D., et al. Five year results of intergroup study E5194: local excision alone (without radiation treatment) for selected patients with ductal carcinoma in situ. Breast Cancer Res Treat 100 suppl 1 (2006) S15#29
17. Solin L.J., Kurtz J., Fourquet A., et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14 3 (1996) 754-763
18. Wong J.S., Kaelin C.M., Troyan S.L., et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 24 7 (2006) 1031-1036
19. Fisher B., Bryant J., Dignam J.J., et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20 20 (2002) 4141-4149
20. Kestin L.L., Goldstein N.S., Martinez A.A., et al. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results. Ann Surg 231 2 (2000) 235-245
21. Huo L., Sneige N., Hunt K.K., et al. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer 107 8 (2006) 1760-1768
22. Eiermann W., Paepke S., Appfelstaedt J., et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study. Ann Oncol 12 11 (2001) 1527-1532
23. Harris J.R. Breast-conserving therapy as a model for creating new knowledge in clinical oncology. Int J Radiat Oncol Biol Phys 35 4 (1996) 641-648
24. Katz S.J., Lantz P.M., Janz N.K., et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol 23 24 (2005) 5526-5533